SciSparc Ltd. (SPRC) revises director Revach Moshe’s share and RSU holdings
Filing Impact
Filing Sentiment
Form Type
3/A
Rhea-AI Filing Summary
SciSparc Ltd. director Revach Moshe filed an amended initial ownership report updating his beneficial holdings. Moshe now reports 3,649 Ordinary Shares directly owned, including 3,333 Ordinary Shares issuable from restricted share units (RSUs) vesting in quarterly installments of 417 shares through December 18, 2027, and 316 Ordinary Shares issuable from RSUs vesting in equal quarterly installments of 40 shares through June 20, 2026. Each RSU represents the right to receive one Ordinary Share. In addition, Moshe holds a stock option to acquire 1 Ordinary Share at an exercise price of 31,941, expiring January 3, 2028.
Positive
- None.
Negative
- None.
Insider Trade Summary
2 transactions reported
Mixed
2 txns
Insider
Revach Moshe
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Stock option (right to buy) | -- | -- | -- |
| holding | Ordinary Shares | -- | -- | -- |
Holdings After Transaction:
Stock option (right to buy) — 1 shares (Direct);
Ordinary Shares — 3,649 shares (Direct)
Footnotes (1)
- This Form is filed solely as an amendment to the Form 3 filed on March 18, 2026. This amendment amends the total number of securities beneficially owned by the reporting person in Table I, and amends and restates the first footnote in Table I as follows: "Includes (i) 3,333 ordinary shares, no par value per share, of the Issuer (the "Ordinary Shares") issuable upon the vesting of restricted share units ("RSUs") in quarterly installments of 417 Ordinary Shares through December 18, 2027; and (ii) 316 Ordinary Shares issuable upon the vesting of RSUs in equal quarterly installments of 40 Ordinary Shares through June 20, 2026. Each RSU represents the right to receive one Ordinary Share." This amendment amends and restates Table II of the initial Form 3, as provided herein. No amendment is made hereby to any other footnotes of the initial Form 3.
Key Figures
Ordinary Shares beneficially owned: 3,649 shares
RSUs vesting through December 18, 2027: 3,333 Ordinary Shares
RSUs vesting through June 20, 2026: 316 Ordinary Shares
+3 more
6 metrics
Ordinary Shares beneficially owned
3,649 shares
Total Ordinary Shares beneficially owned by Revach Moshe after amendment
RSUs vesting through December 18, 2027
3,333 Ordinary Shares
RSUs vesting in quarterly installments of 417 Ordinary Shares
RSUs vesting through June 20, 2026
316 Ordinary Shares
RSUs vesting in equal quarterly installments of 40 Ordinary Shares
Stock option exercise price
31,941
Exercise price for stock option to acquire 1 Ordinary Share
Stock option expiration
January 3, 2028
Expiration date of stock option held by Revach Moshe
Underlying shares for option
1 Ordinary Share
Underlying Ordinary Shares for the reported stock option
Key Terms
restricted share units ("RSUs"), beneficially owned, Stock option (right to buy), Ordinary Shares
4 terms
beneficially owned financial
"amends the total number of securities beneficially owned by the reporting person in Table I"
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
Stock option (right to buy) financial
"Stock option (right to buy) ... underlying security title Ordinary Shares"
FAQ
What does SciSparc (SPRC) director Revach Moshe report owning in this Form 3/A?
Revach Moshe reports 3,649 Ordinary Shares beneficially owned, including Ordinary Shares issuable from RSUs that vest through June 20, 2026 and December 18, 2027, plus a stock option for 1 Ordinary Share.
How many RSUs does SciSparc (SPRC) director Revach Moshe hold and how do they vest?
Moshe holds RSUs for 3,333 Ordinary Shares vesting in quarterly installments of 417 shares through December 18, 2027, and RSUs for 316 Ordinary Shares vesting in equal quarterly installments of 40 shares through June 20, 2026.
What stock option position does Revach Moshe report in SciSparc (SPRC)?
Moshe reports a stock option to buy 1 Ordinary Share of SciSparc, with an exercise price of 31,941 and an expiration date of January 3, 2028, held directly.
What is the purpose of this SciSparc (SPRC) Form 3/A amendment?
The amendment updates the total number of securities beneficially owned in Table I and fully amends and restates Table II of the initial Form 3, without changing other original footnotes.
How are RSUs defined for SciSparc (SPRC) director Revach Moshe in this filing?
Each restricted share unit (RSU) is defined as representing the right to receive one Ordinary Share of SciSparc upon vesting, with vesting occurring in specified quarterly installments through 2026 and 2027.